Results 221 to 230 of about 3,156,311 (293)

Challenges and opportunities in NMIBC management across Latin America: insights from healthcare providers and a patient advocacy group. [PDF]

Ecancermedicalscience
McCully M, Lipkis J, Heller A, Huñis A.
europepmc   +1 more source

Combined Anterior Cruciate Ligament Reconstruction and Extra‐articular Tenodesis Using the Iliotibial Band With Femoral Press‐Fit Fixation: A Low‐Cost and Reproducible Technique

Arthroscopy Techniques, EarlyView.
Abstract The addition of a lateral extra‐articular reinforcement to anterior cruciate ligament reconstruction has been shown to enhance rotational stability and protect the intra‐articular graft. Although several techniques using the iliotibial band have been described, most rely on fixation devices that increase surgical cost and complexity.
José Leonardo Rocha de Faria, Felipe Galvão Abreu, Vitor Barion de Pádua, Valdeci Manoel de Oliveira, Rafael Erthal de Paula, Yuri Di Cavalcanti, Naasson Trindade Cavanellas, José Paulo Gabbi Aramburú Filho, João Antonio Matheus Guimarães, Geraldo da Rocha Motta Filho, Phelippe Valente Maia   +10 more
wiley   +1 more source

Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey Study. [PDF]

JMIR Public Health Surveill
Themistocleous S, Argyropoulos CD, Vogazianos P, Shiamakkides G, Noula E, Nearchou A, Yiallouris A, Filippou C, Stewart FA, Koniordou M, Kopsidas I, Askling HH, Vene S, Gagneux-Brunon A, Prellezo JB, Álvarez-Barco E, Salmanton-García J, Leckler J, Macken AJ, Davis RJ, Azzini AM, Armeftis C, Hellemans M, Di Marzo R, Luis C, Olesen OF, Valdenmaiier O, Jakobsen SF, Nauclér P, Launay O, Mallon P, Ochando J, van Damme P, Tacconelli E, Zaoutis T, Cornely OA, Pana ZD.   +36 more
europepmc   +1 more source

Combined Anterior Cruciate Ligament Reconstruction and Lateral Extra‐articular Tenodesis With Augmented Continuous Iliotibial Band Autograft

Arthroscopy Techniques, EarlyView.
Abstract The purpose of this technical note is to describe a reproducible surgical technique for anterior cruciate ligament reconstruction combined with a lateral tenodesis using a continuous iliotibial band autograft that allows self‐augmentation of graft diameter without the need for additional tendon harvesting.
Gregoire Zerr, David Eichler, Pierre Imbert, Christian Lutz   +3 more
wiley   +1 more source

Patient perspectives on BCMA-targeted therapies for multiple myeloma: a survey conducted in a patient advocacy group. [PDF]

Front Health Serv
Hydren JR, Lin D, Sweeney NW, Wu B, Kim N, Patel S, Sborov DW, Berdeja JG, Anderson LD, Huo S, Hurtado Martínez JA, Ahlstrom JM.   +11 more
europepmc   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Enhancing and leveraging principal investigator and patient advocacy group collaboration in rare disease clinical research-meeting report from the rare Diseases Clinical Research Network. [PDF]

Ther Adv Rare Dis
Wheeden K, Meyers S, Anthony K, Chehade M, Gifford RC, King EC, Seid M.   +6 more
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source